CA
NZ
UK
AU
IND
US
• Cohen's resignation was attributed to personal reasons, with no disagreement cited regarding company operations.
• The appointments were made without disclosed pre‑existing agreements.
• Iovance Biotherapeutics has revised its corporate presentation for use at healthcare conferences and investor meetings.
• The transaction generated $272,000 at $0.32 per share.
• The new President will receive a one‑time equity award valued at roughly $500,000 in restricted stock units.
• Picard Medical (NYSE American: PMI) submitted a corporate presentation to the SEC.1 on July 2, 2026.
• Tenax Therapeutics will showcase its Phase 3 LEVEL clinical trial results at the ESC Congress 2026.
• ADC Therapeutics SA is implementing one-time retention awards for its executives and select employees.
• Avalon GloboCare sold Series F convertible preferred stock and 200,000 common shares for a total of $400,000.
• His resignation follows his appointment to a new executive role at another organization.
Please wait processing your request...